Search : U.S. Supreme Court : Manufacturing : From 10/01/06 To 07/01/07
Number of summaries found: 4
Search For More Summaries
| Court: | U.S. Supreme Court |
| Topic: | Antitrust & Trade Regulation, Commercial Law, Manufacturing, Retail |
| Title: | Leegin Creative Leather Prods., Inc. v. PSKS, Inc. |
| Date: | 06/28/07 |
| Case Number: | 06-480 |
| Summary: | Dr. Miles Medical Co. v. John D. Park & Sons Co., 220 U. S. 373, which makes it per se illegal under section 1 of the Sherman Act for a manufacturer and its distributor to agree on the minimum price the distributor can charge for the manufacturer's goods, is overruled. Vertical price restraints are to be judged by the rule of reason. |
| Court: | U.S. Supreme Court |
| Topic: | Civil Procedure, Corp. Governance, Corporation & Enterprise Law, Evidence, Manufacturing, Securities Law |
| Title: | Tellabs, Inc. v. Makor Issues & Rights, Ltd. |
| Date: | 06/21/07 |
| Case Number: | 06-–484 |
| Summary: | In the context of private securities fraud actions and the pleading requirements of the Private Securities Litigation Reform Act (PSLRA) intended to check abusive litigation, to qualify as "strong" within the intendment of section 21D(b)(2), an inference of scienter must be more than merely plausible or reasonable -- it must be cogent and at least as compelling as any opposing inference of nonfraudulent intent. |
| Court: | U.S. Supreme Court |
| Topic: | Antitrust & Trade Regulation, Civil Procedure, Government Law, Manufacturing |
| Title: | Watson v. Philip Morris Cos., Inc. |
| Date: | 06/11/07 |
| Case Number: | 05-1284 |
| Summary: | In the context of the federal officer removal statute, the fact that a federal regulatory agency directs, supervises, and monitors a company's activities in considerable detail does not bring that company within 28 U.S.C. section 1442(a)(1)'s scope so as to permit removal of the action from state court to federal court. |
| Court: | U.S. Supreme Court |
| Topic: | Civil Procedure, Contracts, Drugs & Biotech, Intellectual Property, Manufacturing, Patent |
| Title: | MedImmune, Inc. v. Genentech, Inc. |
| Date: | 01/09/07 |
| Case Number: | 05–608 |
| Summary: | Dismissal of a drug manufacturer's patent and contract declaratory judgment action, for lack of subject-matter jurisdiction, is reversed where petitioner was not required, insofar as Article III is concerned, to break or terminate its 1997 license agreement before seeking a declaratory judgment in federal court that the underlying patent was invalid, unenforceable, or not infringed. |